The company identifies pharmaceutical spending in emerging markets as a key growth driver, projecting a 5% to 8% compound annual growth rate through 2030. This expansion requires highly localized knowledge and information assets, creating needs for regional partners and technology that can scale globally.
Filing excerpt
According to the IQVIA Institute, it is estimated that spending on pharmaceuticals in emerging markets will expand at a 5% to 8% compound annual growth rate (“CAGR”) through 2030.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kinternationalGrowthGet every 10-K signal for IQVIA and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at IQVIA this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/12546cdf-33a3-4882-abc3-ac2bc262cd73 returns this record as JSON. POST /v1/companies/enrich returns every signal for iqvia.com.
{
"signal_id": "12546cdf-33a3-4882-abc3-ac2bc262cd73",
"signal_type": "sec-10k",
"signal_subtype": "internationalGrowth",
"detected_at": "2026-02-24T09:23:47.338+00:00",
"company": {
"name": "IQVIA",
"domain": "iqvia.com"
},
"data": {
"detail": "The company identifies pharmaceutical spending in emerging markets as a key growth driver, projecting a 5% to 8% compound annual growth rate through 2030. This expansion requires highly localized knowledge and information assets, creating needs for regional partners and technology that can scale globally.",
"metrics": {
"pct": 0.065,
"timeframe": "multi_year",
"pct_context": "Projected CAGR for pharmaceutical spending in emerging markets"
},
"summary": "IQVIA targets emerging markets for growth, projecting 5-8% CAGR through 2030",
"excerpts": "According to the IQVIA Institute, it is estimated that spending on pharmaceuticals in emerging markets will expand at a 5% to 8% compound annual growth rate (“CAGR”) through 2030.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1478242/000162828026008322/iqv-20251231.htm",
"filing_date": "2026-02-17",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Global tools needed",
"signal_category": "market",
"regions_mentioned": [
"emerging markets",
"Asia"
]
}
}
curl https://signals.autobound.ai/v1/signals/12546cdf-33a3-4882-abc3-ac2bc262cd73 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"iqvia.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.